Abstract P3-02-03: Prognostic Value of Circulating Tumor Cells (CTC) in HER-2 Positive Metastatic Breast Cancer (MBC) Patients (pts) Treated with Anti-HER2-Based TherapyMario Giuliano, Massimo Cristofanilli, Vicente Valero et al.|Cancer Research|2010Cited by 1